We are live on ! Find out more
VTAE

VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE

Delisted

VTAE was delisted on the 24th of October, 2016.

Back to rankings

15 hedge funds and large institutions have $45M invested in VITAE PHARMACEUTICALS INC COMMON STOCK in 2014 Q3 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
+15
Holders Change %
–
% of All Funds
0.44%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
15
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
+$20.3M
2
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
+$6.41M
3
BI
BVF Inc
California
+$5.18M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.76M
5
WT
Wellcome Trust
United Kingdom
+$4.04M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$19.9M +$20.3M +2,613,199 New
AWMDMG
2
Austin W. Marxe & David M. Greenhouse
New York
$6.29M +$6.41M +825,000 New
BI
3
BVF Inc
California
$5.08M +$5.18M +666,000 New
Fidelity Investments
4
Fidelity Investments
Massachusetts
$4.67M +$4.76M +612,500 New
WT
5
Wellcome Trust
United Kingdom
$3.96M +$4.04M +519,410 New
Alyeska Investment Group
6
Alyeska Investment Group
Illinois
$1.39M +$1.42M +182,609 New
JP Morgan Chase
7
JP Morgan Chase
New York
$953K +$972K +125,000 New
IC
8
Intel Corp
California
$807K +$822K +105,751 New
Millennium Management
9
Millennium Management
New York
$585K +$596K +76,624 New
Marshall Wace
10
Marshall Wace
United Kingdom
$569K +$580K +74,568 New
WAM
11
Weiss Asset Management
Massachusetts
$305K +$311K +40,000 New
Deutsche Bank
12
Deutsche Bank
Germany
$248K +$254K +32,609 New
SIP
13
Stoneridge Investment Partners
Pennsylvania
$169K +$172K +22,157 New
GSC
14
Ground Swell Capital
South Carolina
$12K +$11.8K +1,521 New
TRCT
15
Tower Research Capital (TRC)
New York
$1K +$1.09K +140 New

VTAE Hedge Fund Activity: Q3 2014 in Review

15 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) for Q3 2014, worth a combined $45M.

Buyers outnumbered sellers: 15 funds opened new VTAE positions and 0 closed out — a net gain of 15 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was NEA Management Company, opening a new position worth an estimated $20.3M.

  • 15 institutional investors held VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) as of Q3 2014, up from 0 in Q2 2014.
  • Funds reported $45M of VITAE PHARMACEUTICALS INC COMMON STOCK stock for Q3 2014.
  • 15 funds opened new VITAE PHARMACEUTICALS INC COMMON STOCK positions in Q3 2014 and 0 closed out, a net change of +15 holders.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK buyer in Q3 2014 was NEA Management Company, an estimated $20.3M added.

Based on aggregated 13F filings for Q3 2014.